Home/Filings/4/0001192482-18-000021
4//SEC Filing

Mattila Jyrki 4

Accession 0001192482-18-000021

CIK 0001588972other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 8:51 PM ET

Size

7.2 KB

Accession

0001192482-18-000021

Insider Transaction Report

Form 4
Period: 2018-01-02
Mattila Jyrki
Executive VP, Business Dev.
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-01-02+23,00023,000 total
    Exercise: $9.04Exp: 2028-01-02Common Stock (23,000 underlying)
  • Award

    Common Stock

    2018-01-02+11,50011,500 total
Footnotes (2)
  • [F1]All shares of common stock are represented by unvested restricted stock units that will vest in four equal annual installments beginning January 2, 2019, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
  • [F2]The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.

Issuer

Recro Pharma, Inc.

CIK 0001588972

Entity typeother

Related Parties

1
  • filerCIK 0001297318

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 8:51 PM ET
Size
7.2 KB